Telemedicine vs. In-person Delivery of Cognitive Behavioral Treatment of Insomnia: a Mixed Methods Analysis
| Status: | Recruiting |
|---|---|
| Conditions: | Insomnia Sleep Studies |
| Therapuetic Areas: | Psychiatry / Psychology |
| Healthy: | No |
| Age Range: | 21 - Any |
| Updated: | 2/14/2019 |
| Start Date: | November 21, 2017 |
| End Date: | October 1, 2020 |
| Contact: | Paul Gunter, M.S. |
| Email: | Paul.Gunter@pennmedicine.upenn.edu |
| Phone: | 215-746-1258 |
Cognitive behavioral therapy for insomnia (CBT-I) has been the 'gold standard' for the
treatment of insomnia. There is a need to increase access to treatment, particularly for
patients in more rural locations where providers may be scarce. One solution is to utilize
telemedicine which is "the use of electronic communications to provide and support health
care when distance separates the provider from the patient." So the purpose of the study is
to determine if receiving CBT-I by video teleconferencing works just as well as in-person
treatment.
treatment of insomnia. There is a need to increase access to treatment, particularly for
patients in more rural locations where providers may be scarce. One solution is to utilize
telemedicine which is "the use of electronic communications to provide and support health
care when distance separates the provider from the patient." So the purpose of the study is
to determine if receiving CBT-I by video teleconferencing works just as well as in-person
treatment.
Inclusion Criteria:
- Meet current DSM5 criteria for Insomnia Disorder as determined by clinician interview
- ISI score greater than 14, with self-reported duration of insomnia of at least 3
months
- Ability to read and speak English
- Own a personal computer with an internet connection sufficient to utilize the SleepTM
and REDCap platform
- BMI less than 30
- Between the ages of 21-50
Exclusion Criteria:
- Unable or unwilling to provide informed consent
- Individuals with an untreated sleep disorder other than insomnia (Individuals with
sleep apnea who are adherent with CPAP treatment (average 4 hours use per night) will
be eligible to participate)
- A clinically unstable medical condition as defined by a new diagnosis or change in
medical management in the previous 2 months
- Individuals with substance abuse/dependence, bipolar disorder, delirium, dementia,
amnestic disorder, schizophrenia, and other psychotic disorders
- Individuals with prominent current suicidal or homicidal ideation
- Unable to perform tests due to inability to communicate verbally, inability to read
and write; less than a 5th grade reading level; visual, hearing, or cognitive
impairment
- Any use of medications or OTC products that might impact sleep or metabolism
We found this trial at
1
site
3451 Walnut St
Philadelphia, Pennsylvania 19104
Philadelphia, Pennsylvania 19104
1 (215) 898-5000
Phone: 215-746-1258
Univ of Pennsylvania Penn has a long and proud tradition of intellectual rigor and pursuit...
Click here to add this to my saved trials
